| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 61.183 | 85.199 | 88.673 | 184.232 | 203.356 | 149.159 | 199.620 | 214.338 | 228.076 | 275.156 |
| Total Income - EUR | 61.371 | 85.255 | 88.696 | 185.168 | 203.373 | 150.556 | 199.620 | 214.380 | 228.206 | 278.490 |
| Total Expenses - EUR | 54.288 | 51.959 | 62.850 | 55.218 | 47.713 | 40.454 | 46.779 | 56.139 | 59.693 | 109.354 |
| Gross Profit/Loss - EUR | 7.083 | 33.296 | 25.845 | 129.950 | 155.660 | 110.102 | 152.841 | 158.241 | 168.513 | 169.136 |
| Net Profit/Loss - EUR | 5.242 | 32.444 | 24.958 | 128.100 | 153.627 | 108.889 | 150.884 | 156.140 | 166.277 | 160.948 |
| Employees | 1 | 3 | 3 | 3 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Oftaclinic Grup Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 20.451 | 8.606 | 6.599 | 9.153 | 13.671 | 10.108 | 7.164 | 5.758 | 4.317 | 2.943 |
| Current Assets | 19.089 | 36.254 | 30.746 | 131.323 | 150.875 | 109.563 | 152.706 | 160.050 | 166.268 | 164.561 |
| Inventories | 109 | 108 | 106 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 582 | 26.889 | 22.183 | 124.229 | 144.626 | 101.348 | 147.037 | 159.273 | 129.971 | 115.780 |
| Cash | 6.643 | 4.006 | 3.273 | 1.988 | 1.224 | 3.285 | 849 | 777 | 16.080 | 48.782 |
| Shareholders Funds | 38.238 | 42.835 | 35.174 | 138.129 | 163.461 | 118.536 | 157.292 | 162.568 | 166.326 | 160.997 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.437 | 2.172 | 2.337 | 2.347 | 2.142 | 2.132 | 3.098 | 3.241 | 4.259 | 7.413 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Oftaclinic Grup Srl